| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $4.5B | $3.0B | $1.9B | $1.4B | $1.8B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | $0.4B | $0.3B | $0.3B | $0.4B | $0.4B |
| SG&A Expense | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | $1.9B | $1.4B | $-0.5B | $-1.0B | $-3.7B |
| EPS (Basic) | $2.12 | $1.60 | $-0.61 | $-1.17 | $-7.49 |
| EPS (Diluted) | $2.05 | $1.56 | $-0.61 | $-1.17 | $-7.49 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $38.1B | $26.2B | $32.3B | $23.3B | $19.8B |
| Current Assets | $36.3B | $25.1B | $31.8B | $22.9B | $19.3B |
| Cash & Equivalents | $4.3B | $4.3B | $4.8B | $6.3B | $6.3B |
| Total Liabilities | $29.0B | $18.2B | $25.6B | $16.4B | $12.5B |
| Current Liabilities | $28.8B | $18.1B | $25.5B | $16.3B | $12.3B |
| Stockholders' Equity | — | $8.0B | $6.7B | $7.0B | $7.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $-0.2B | $1.2B | $-0.9B | $-0.9B |
| Investing Cash Flow | $0.1B | $-0.1B | $-0.6B | $-0.1B | $-0.2B |
| Capital Expenditures | — | — | — | — | — |
| Financing Cash Flow | $-0.6B | $-0.3B | $-0.6B | $0.0B | $5.2B |